Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reflections on Living with Lupus, and on Treating It

Simon M. Helfgott, MD  |  Issue: April 2012  |  April 6, 2012

A few years later, for the first time, Larry missed his appointment with me. I knew that something must be terribly wrong when I failed to see him holding court in the waiting area 30 minutes before his appointment. I tried calling his home phone, but the line was constantly busy. About an hour later, I received a call from his mother, who told me that she’d found Larry dead in his bed. An autopsy was not performed, so I can only guess that Larry died of a cardiovascular event.

Larry’s Lessons

What did I learn from Larry? Perhaps the most important lesson was to follow the sage advice of his favorite philosopher, the baseball legend Casey Stengel, who once decreed: “Never make predictions, especially about the future.” This was Larry’s credo; he always lived life to the fullest. Never mind that he faced a life-threatening cardiac tamponade, or that a few years later he would be told that lupus nephritis would eventually destroy his kidneys and lead him to the dialysis unit. And that, for twenty years, somehow he kept walking on a pair of totally worn out hips that should have been replaced a decade earlier. And how he only could see half of his visual fields. Nothing fazed Larry. Was it a strong sense of denial? Maybe. But I always knew that he understood the serious nature of his disease. He just wanted to imagine a better outcome. He once confided that he used positive imagery as a way to create a world where he could live his life as though he had no illness.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Larry was not a therapeutic nihilist. He would have only partially agreed with the patient–author of Anatomy of an Illness, Norman Cousens, who once said that, “drugs are not always necessary, [but] belief in recovery always is.” Larry recognized his need for treatment. Yes, be optimistic, but don’t leave everything to chance. When I look back at Larry’s treatment and compare it to what we would have offered him today, there is literally no difference: steroids, azathioprine, hydroxychloroquine, cyclophosphamide. Sadly, not much has changed over the past 40 years of lupus therapeutics. Yes, we are better at treating the infectious complications that sicken our lupus patients and maybe we are improving the management of their cardiovascular risks. But we owe it to Larry to do a far better job at taming the lupus beast.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOpinionRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:cardiac tamponadedrugHelfgottHYDROXYCHLOROQUINELupusPathogenesispatient careprednisonerheumatologistSystemic lupus erythematosustherapeuticsTreatment

Related Articles

    Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances

    December 1, 2014

    Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies

    Rheumatology Guy

    October 1, 2009

    Sung to the Tune of “American Pie”

    The Rheumatologist as Detective

    February 1, 2015

    A case of difficult-to-diagnose Whipple’s disease

    Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease

    December 4, 2017

    A recent study suggests novel markers of dry eye disease can be found in the lacrimal fluid and tear fluid of patients. Researchers analyzed the proteins in these fluids and found immune response-related proteins are upregulated at the protein level in lacrimal fluid of patients with dry eye disease and may be an important biomarker…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences